← Previous Post: | Next Post:

 

Excellent summary of the pharmaceutical industry…

… here, on a  Wharton School blogUniversity Diaries follows lots of campus stories involving pharma-compromised professors and conflict of interest, and it’s easy to get lost in all the cases.  This article provides the big picture.

Margaret Soltan, October 15, 2009 10:55AM
Posted in: conflict of interest

Trackback URL for this post:
https://www.margaretsoltan.com/wp-trackback.php?p=18302

One Response to “Excellent summary of the pharmaceutical industry…”

  1. Brad Says:

    I don’t understand where Wharton gets the $1.2 billion figure for the Pfizer penalty. "In the pipeline" and others say the figure is $2.3 billion. Either it’s wrong or it’s not wrong. If it’s not wrong, I’m guessing that the penalty decreases Pfizer’s income, and therefore decreases the tax they pay. So, half of the the penalty is made up of tax savings?

Comment on this Entry

Latest UD posts at IHE

Archives

Categories